ONL Therapeutics' Grant - II Round

ONL Therapeutics raised a round of funding on March 21, 2017. Investors include National Eye Institute.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. Existing therapies have significant limitations and none address the initial ne…

Articles about ONL Therapeutics' Grant - II Round: